NASDAQ:AIKI AIkido Pharma (AIKI) Stock Price, News & Analysis $2.03 -0.10 (-4.69%) As of 10/13/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsSEC Filings About AIkido Pharma Stock (NASDAQ:AIKI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get AIkido Pharma alerts:Sign Up Key Stats Today's Range$2.02▼$2.1150-Day Range$1.94▼$3.1452-Week Range$3.31▼$11.48Volume78,797 shsAverage Volume79,326 shsMarket Capitalization$11.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview AIkido Pharma Inc. was a development-stage biotechnology company focused on identifying, acquiring and developing therapeutic candidates for cancer and other serious diseases. Its activities centered on advancing early-stage pharmaceutical programs rather than marketing an established portfolio of commercial products. The company pursued drug-development opportunities through research collaborations, intellectual-property licensing and strategic acquisitions. Its programs included investigational treatments aimed at oncology applications, including pancreatic cancer, as well as other therapeutic areas explored through external technologies and partnerships. AIkido Pharma’s operations were primarily research and development-oriented, and publicly available information provides limited detail about a broad commercial presence, geographic operations or a current leadership team. The company’s business profile and program priorities may have changed over time as it evaluated potential licensing and development opportunities.AI Generated. May Contain Errors. Read More Receive AIKI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AIkido Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AIKI Stock News HeadlinesAIkido Pharma Inc. Common Stock (AIKI)July 29, 2026 | nasdaq.comCrypto, Real Estate, And More: The Lesser-Known 'Dealmakers' Behind Trump’s $5 Billion EmpireAugust 20, 2025 | msn.comRent out your stocks?If you owned a rental house, you would collect rent while you waited for it to rise in value. A covered call lets you do something similar with stocks you already own. Own at least 100 shares and you can get paid cash today for agreeing to sell them at a higher price later. That cash is yours to keep no matter what happens next. Bill Poulos breaks it down in The Retirement Paycheck Playbook, normally $29.97, free today.October 14 at 1:00 AM | Profits Run (Ad)How an Obscure Firm Bet on the Trumps and Became Their Go-To DealmakerAugust 19, 2025 | msn.comDon Jr. And Eric Trump Could Soon Sell $9.6 Million In Stock Granted For Brief Advisory Board Tenure, SEC Filing RevealsApril 26, 2025 | msn.comDon Jr. And Eric Trump Landed $3 Million In Stock For Joining Firm’s Advisory Board That Had Little Public Presence Before Their AppointmentApril 17, 2025 | msn.comTrump Sons Joined Dominari Holding’s Advisory Board–But There’s Little Public Record The Board Existed BeforehandMarch 7, 2025 | forbes.comDon Jr. and Eric Trump invest in small biotech turned fintech based in Trump Tower, sending stock skywardFebruary 12, 2025 | msn.comSee More Headlines AIKI Stock Analysis - Frequently Asked Questions How have AIKI shares performed this year? AIkido Pharma's stock was trading at $4.95 on January 1st, 2026. Since then, AIKI shares have decreased by 57.0% and is now trading at $2.13. When did AIkido Pharma's stock split? AIkido Pharma's stock reverse split on the morning of Tuesday, June 7th 2022.The 1-17 reverse split was announced on Tuesday, June 7th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 7th 2022. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split. Does AIkido Pharma have any subsidiaries? AIkido Pharma subsidiaries include Hoth Therapeutics. How do I buy shares of AIkido Pharma? Shares of AIKI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of AIkido Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that AIkido Pharma investors own include Bionano Genomics (BNGO), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Jaguar Animal Health (JAGX), Ocugen (OCGN), Palantir Technologies (PLTR) and Castor Maritime (CTRM). Company Calendar Today10/14/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Capital Markets Sub-IndustryInvestment Banking & Brokerage Current SymbolNASDAQ:AIKI CIK12239 Webwww.spherix.com Phone(112) 745-1374Fax703-992-9348Employees4Year Founded1967Profitability EPS (Trailing Twelve Months)($3.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.17 million Net MarginsN/A Pretax MarginN/A Return on Equity-18.21% Return on Assets-16.94% Debt Debt-to-Equity RatioN/A Current Ratio29.54 Quick Ratio29.54 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$19.27 per share Price / Book0.11Miscellaneous Outstanding Shares5,485,000Free Float5,013,000Market Cap$11.68 million OptionableNot Optionable Beta0.93 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:AIKI) was last updated on 10/13/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.